Open AccessPrediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan
Author(s) -
Atsushi Hiraoka,
Kojiro Michitaka,
Takashi Kumada,
Namiki Izumi,
Masumi Kadoya,
Norihiro Kokudo,
Shoji Kubo,
Yutaka Matsuyama,
Osamu Nakashima,
Michiie Sakamoto,
Tadatoshi Takayama,
Takashi Kobayashi,
Kosuke Kashiwabara,
Susumu Eguchi,
Tatsuya Yamashita,
Masatoshi Kudo
Publication year - 2019
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000495944
Subject(s) - medicine , hepatocellular carcinoma , hazard ratio , confidence interval , gastroenterology , proportional hazards model , tumor marker , multivariate analysis , predictive marker , database , oncology , cancer , computer science
Adequate assessment of transcatheter arterial chemoembolization (TACE)-refractory status has become more important for switching treatment in intermediate-stage (BCLC-B) hepatocellular carcinoma (HCC) patients treated with TACE. The usefulness of a previously proposed tumor marker score for predicting prognosis of BCLC-B HCC patients treated with TACE was investigated.